Recording of the victims identification data, nature of the exposure, place and time the exposure took place, the identity of the informant and the time the victim presented for medical care.

If the exposure is of the injecting-drug use type, the medical officer should determine the number of persons sharing the injection device and the length of time the victim has been on the method. (The risk of HIV transmission per episode of IV needle exposure is estimated at 0.67%).

Pre-test counselling the victim and obtaining of informed consent for HIV testing. Blood- samples or other diseases which could be transmitted through the same exposure (such as syphilis, Hepatitis B, Hepatitis C) should be taken along side that for HIV). There is hardly any benefit in recommending antiretroviral chemophylaxis for those who expose themselves to HIV through injecting-drug use unless they are willing to be rehabilitated through counselling and psychiatric care aimed at weaning them from their dangerous habit.

Those who get exposed to HIV through RTAs and other mass accidents where multiple exposure to blood and body fluids of other victims of the same accident can not be ruled out, should be recommended for Antiretroviral chemoprophylaxis. The chemoprophylaxis should be taken for a period of 28 days. The computed risk of HIV transmission (computed for available data on the local HIV prevalence multiplied by the number of RTA victims assisted) should also be disclosed to the patient.